Login
Express Voncert Phoenix
Symbol:
ZMRAAV
ISIN:
CH1166198270
Issuer:
Bank Vontobel
SIX Structured Products trading
| SIX Structured Products | Bid | Ask | Notation | |
|---|---|---|---|---|
| Please note that data is only available after start of trading. | ||||
Performance
| Closing prev. day | 15.40 | ||||
| Diff. absolute / % | -2.80 | -18.18% | |||
Determined prices
| Last Price | - | Volume | - | |
| Time | - | Date | - |
More Product Information
| Details | Underlying | Payment profile | Risk Indicator | Information & Tools | Similar Products |
Core Data
| Name | Express Voncert Phoenix |
| ISIN | CH1166198270 |
| Valor | 116619827 |
| Symbol | ZMRAAV |
| Type | Express Certificates |
| SVSP Code | 1260 |
| Barrier reached | No |
| COSI Product | No |
| Exercise type | European |
| Currency | US Dollar |
| First Trading Date | 30/03/2022 |
| Date of maturity | 01/04/2027 |
| Last trading day | 24/03/2027 |
| Settlement Type | Path-dependent |
| IRS 871m | Potentially in scope for combined transactions |
| Currency safeguarded | No |
| Pricing | Dirty |
| Issuer | Bank Vontobel |
Underlyings
| Name | Moderna Inc. |
| ISIN | US60770K1079 |
| Price |
21.5425 EUR
|
| Date | 10/04/25 17:52 |
| Ratio | 0.17818 |
| Cap | 178.18 USD |
| Barrier | 89.09 USD |
Key data
| Ask Price (basis for calculation) | 15.2800 |
| Distance to Cap | -153.88 |
| Distance to Cap in % | -633.25% |
| Is Cap Level reached | No |
| Distance to Barrier | -64.79 |
| Distance to Barrier in % | -266.63% |
| Is Barrier reached | No |
market maker quality Date: 09/04/2025
| Average Spread | 23.14% |
| Last Best Bid Price | 12.64 % |
| Last Best Ask Price | 15.40 % |
| Last Best Bid Volume | 50,000 |
| Last Best Ask Volume | 50,000 |
| Average Buy Volume | 31,598 |
| Average Sell Volume | 31,598 |
| Average Buy Value | 3,938 USD |
| Average Sell Value | 4,962 USD |
| Spreads Availability Ratio | 98.68% |
| Quote Availability | 98.68% |
Cookie notification
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)